Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Letter From The Editor: Important Information On PharmAsia News

This article was originally published in PharmAsia News

Executive Summary

PharmAsia News will cease publication as a stand-alone product at the end of June/early July. However, the on-the-ground team of journalists who produce PAN will all continue to provide the same in-depth insight, news, and analysis as previously, and this content will be made available through Informa’s updated Scrip platform. All PAN subscribers will receive Scrip from early July, and Asia-Pacific regulatory content will be available through the expanded Pink Sheet and its new platform.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts